title: Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
authors.affiliation: Department of Neurology, Beilinson Medical Center, Petah Tiqva, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Melamed
authors.forename: J
authors.initials: J
authors.lastname: Zoldan
authors.forename: G
authors.initials: G
authors.lastname: Friedberg
authors.forename: I
authors.initials: I
authors.lastname: Ziv
authors.forename: A
authors.initials: A
authors.lastname: Weizmann
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000523:psychology*; D011605:Psychoses, Substance-Induced / Q000209:etiology / Q000523:psychology; D012701:Serotonin / Q000502:physiology*
chemical_list: D000978:Antiparkinson Agents; D012701:Serotonin; D007980:Levodopa